ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 298

$566K Total Retail Price of All Prescriptions

Rank: 16 out of 298

370 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 370 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 370 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,917 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
WARFARIN SODIUM 328 249 1 7
LEVOTHYROXINE SODIUM 284 238 2 1
OMEPRAZOLE 249 138 3 3
LISINOPRIL 240 178 4 4
TRAMADOL HCL 234 144 5 15
SIMVASTATIN 222 218 6 2
AMLODIPINE BESYLATE 201 167 7 6
POLYETHYLENE GLYCOL 3350 188 67 8 29
FUROSEMIDE 170 155 9 5
HYDROCODONE-ACETAMINOPHEN 167 88 S3 10 8
METOPROLOL TARTRATE 165 149 11 9
DONEPEZIL HCL 140 140 12 22
TAMSULOSIN HCL 139 114 13 24
SERTRALINE HCL 130 71 14 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 75 15 30
GABAPENTIN 127 69 16 20
METOPROLOL SUCCINATE 122 98 17 12
BACLOFEN 118 41 18 97
METOCLOPRAMIDE HCL 113 22 19 103
NEXIUM 109 33 20 40
MELOXICAM 96 66 21 41
FLUOXETINE HCL 96 33 21 50
CARVEDILOL 93 92 23 23
RANITIDINE HCL 92 36 24 59
AMITRIPTYLINE HCL 91 62 R 25 51
ATORVASTATIN CALCIUM 88 72 26 14
CITALOPRAM HBR 78 39 27 17
DIVALPROEX SODIUM 78 0 27 91
FENTANYL 76 50 S2 29 32
CARBAMAZEPINE 72 0 30 105
HYDROCHLOROTHIAZIDE 71 67 31 13
POTASSIUM CHLORIDE 68 50 32 11
MIRTAZAPINE 66 37 33 37
ALLOPURINOL 65 33 34 28
ZOLPIDEM TARTRATE 64 30 35 25
CLOPIDOGREL 63 56 36 36
ATENOLOL 61 59 37 16
SPIRONOLACTONE 59 59 38 34
BUPROPION XL 58 19 39 166
DIOVAN 57 47 40 47
METFORMIN HCL 56 44 41 10
SUCRALFATE 56 25 41 104
SPIRIVA 55 50 43 55
ALENDRONATE SODIUM 54 40 44 21
DIGOXIN 54 44 44 27
PROCTOZONE-HC 53 39 46 231
NAMENDA 53 36 46 35
FINASTERIDE 52 39 48 66
CARAFATE 52 15 48 236
NITRO-BID 52 0 10 48 236
OXYBUTYNIN CHLORIDE ER 51 39 51 121
AZITHROMYCIN 50 30 52 63
ESCITALOPRAM OXALATE 50 23 52 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.